Uri Tabori

What is he best known for?

The fields of study Uri Tabori is best known for:

• Gene
• Cancer
• DNA

Uri Tabori bridges between several scientific fields such as Glioma and Medulloblastoma in his study of Cancer research. His study connects Cancer research and Glioma. He undertakes interdisciplinary study in the fields of Medulloblastoma and Gene through his research. Uri Tabori carries out multidisciplinary research, doing studies in Gene and Epigenetics. Uri Tabori performs multidisciplinary study in the fields of Epigenetics and Genetics via his papers. His Genetics study frequently draws parallels with other fields, such as Germline mutation. Internal medicine is intertwined with Cancer and Cohort in his research. Uri Tabori performs multidisciplinary study in Cancer and DNA methylation in his work. His Cohort study frequently draws connections between adjacent fields such as Internal medicine.

His most cited work include:

• Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden (2072 citations)
• Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma (1966 citations)
• Intertumoral Heterogeneity within Medulloblastoma Subgroups (708 citations)

What are the main themes of his work throughout his whole career to date

His Internal medicine study frequently links to other fields, such as Cohort. Cohort connects with themes related to Internal medicine in his study. Uri Tabori combines Oncology and Radiation therapy in his studies. His Cancer research study frequently links to related topics such as Glioma. As part of his studies on Glioma, Uri Tabori often connects relevant areas like Cancer research. He combines Gene and Genetics in his research. His Genetics study often links to related topics such as Germline mutation. He combines Germline mutation and Mutation in his studies. Uri Tabori incorporates Mutation and Cancer in his studies.

Uri Tabori most often published in these fields:

• Internal medicine (66.49%)
• Oncology (49.48%)
• Cancer research (48.45%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.